Sio Gene Therapies Banner Image

Sio Gene Therapies

  • Ticker SIOX
    Exchange OTC More
  • Industry Biotechnology More
  • Sector Healthcare More
Sio Gene Therapies Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Sio Gene Therapies is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutesMore, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.
Sio Gene Therapies

Most Recent Annual Report

Sio Gene Therapies
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Sio Gene Therapies Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!